Market Cap

Infant Bacterial Therapeutics AB Market Capitalization:

kr1.27 Billion

SEK as of Jan. 1, 2024

US$126.5 Million

business Infant Bacterial Therapeutics AB Company Profile

Infant Bacterial Therapeutics AB Main Stock Listing

OMX: IBT.B

Market Capitalization History of Infant Bacterial Therapeutics AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Infant Bacterial Therapeutics AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr1.27 B 93.99%
Jan. 1, 2023 kr656.3 M -12.86%
Jan. 1, 2022 kr753.2 M -50.24%
Jan. 1, 2021 kr1.51 B -20.88%
Jan. 1, 2020 kr1.91 B -4.76%
Jan. 1, 2019 kr2.01 B 45.45%
Jan. 1, 2018 kr1.38 B 150.57%
Jan. 1, 2017 kr551.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Infant Bacterial Therapeutics AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Infant Bacterial Therapeutics AB has the following listings and related stock indices.


Stock: OMX: IBT.B

Stock: XSTU: 9IB

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.